Intellectual property and funding: fueling Chinese synbio

Trends Biotechnol. 2023 Nov 16:S0167-7799(23)00315-3. doi: 10.1016/j.tibtech.2023.10.012. Online ahead of print.ABSTRACTAs China emerges as a synthetic biology (synbio) global leader, it faces distinct science-society challenges. Our series offers a snapshot of China's synbio state, emphasizing the intersection and its policy implications. The debut piece elucidates the intellectual property rights (IPR)-funding interplay in China's expanding synbio territory, underlining its key role in driving innovation and commercialization.PMID:37980185 | DOI:10.1016/j.tibtech.2023.10.012
Source: Trends in Biotechnology - Category: Biotechnology Authors: Source Type: research